TY - JOUR
T1 - Specific Binding of Cu(II) Ions to Amyloid-Beta Peptides Bound to Aggregation-Inhibiting Molecules or SDS Micelles Creates Complexes that Generate Radical Oxygen Species
AU - Tiiman, Ann
AU - Luo, Jinghui
AU - Wallin, Cecilia
AU - Olsson, Lisa
AU - Lindgren, Joel
AU - Jarvet, Jüri
AU - Per, Roos
AU - Sholts, Sabrina B.
AU - Rahimipour, Shai
AU - Abrahams, Jan Pieter
AU - Karlström, Amelie Eriksson
AU - Gräslund, Astrid
AU - Wärmländer, Sebastian K.T.S.
N1 - Publisher Copyright:
© 2016-IOS Press and the authors. All rights reserved.
PY - 2016/10/4
Y1 - 2016/10/4
N2 - Aggregation of the amyloid-beta (Aβ) peptide into insoluble plaques is a major factor in Alzheimer's disease (AD) pathology. Another major factor in AD is arguably metal ions, as metal dyshomeostasis is observed in AD patients, metal ions modulate Aβ aggregation, and AD plaques contain numerous metals including redox-active Cu and Fe ions. In vivo, Aβ is found in various cellular locations including membranes. So far, Cu(II)/Aβ interactions and ROS generation have not been investigated in a membrane environment. Here, we study Cu(II) and Zn(II) interactions with Aβ bound to SDS micelles or to engineered aggregation-inhibiting molecules (the cyclic peptide CP-2 and the Z Aβ3 (12-58)Y18L Affibody molecule). In all studied systems the Aβ N-terminal segment was found to be unbound, unstructured, and free to bind metal ions. In SDS micelles, Aβ was found to bind Cu(II) and Zn(II) with the same ligands and the same K D as in aqueous solution. ROS was generated in all Cu(II)/Aβ complexes. These results indicate that binding of Aβ to membranes, drugs, and other entities that do not interact with the Aβ N-terminal part, appears not to compromise the N-terminal segment's ability to bind metal ions, nor impede the capacity of N-terminally bound Cu(II) to generate ROS.
AB - Aggregation of the amyloid-beta (Aβ) peptide into insoluble plaques is a major factor in Alzheimer's disease (AD) pathology. Another major factor in AD is arguably metal ions, as metal dyshomeostasis is observed in AD patients, metal ions modulate Aβ aggregation, and AD plaques contain numerous metals including redox-active Cu and Fe ions. In vivo, Aβ is found in various cellular locations including membranes. So far, Cu(II)/Aβ interactions and ROS generation have not been investigated in a membrane environment. Here, we study Cu(II) and Zn(II) interactions with Aβ bound to SDS micelles or to engineered aggregation-inhibiting molecules (the cyclic peptide CP-2 and the Z Aβ3 (12-58)Y18L Affibody molecule). In all studied systems the Aβ N-terminal segment was found to be unbound, unstructured, and free to bind metal ions. In SDS micelles, Aβ was found to bind Cu(II) and Zn(II) with the same ligands and the same K D as in aqueous solution. ROS was generated in all Cu(II)/Aβ complexes. These results indicate that binding of Aβ to membranes, drugs, and other entities that do not interact with the Aβ N-terminal part, appears not to compromise the N-terminal segment's ability to bind metal ions, nor impede the capacity of N-terminally bound Cu(II) to generate ROS.
KW - Alzheimer's disease
KW - copper-binding protein
KW - hydrogen peroxide
KW - membrane chemistry
KW - neurodegeneration
KW - protein aggregation
UR - http://www.scopus.com/inward/record.url?scp=84990053593&partnerID=8YFLogxK
U2 - 10.3233/jad-160427
DO - 10.3233/jad-160427
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 27567855
AN - SCOPUS:84990053593
SN - 1387-2877
VL - 54
SP - 971
EP - 982
JO - Journal of Alzheimer's Disease
JF - Journal of Alzheimer's Disease
IS - 3
ER -